ScreenerHero

VETO Vetoquinol SA

EPA · FR · Healthcare · Drug Manufacturers - Specialty & Generic · vetoquinol.com
73.80EUR+0.27%Mkt Cap: 932.50M $P/E: 13.57

Vetoquinol SA, a veterinary pharmaceutical company, engages in designing, developing, and selling of veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Paci…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$64.30BUSDP/E 25.0
TAK
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
$57.06BUSD
TEVA
Teva Pharmaceutical Industries Limited Ordinary Shares
$46.10BUSDP/E 65.9
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$38.70BUSDP/E 18.3
ZOE
Zoetis Inc.
$28.27BUSDP/E 12.1
ZTS
Zoetis Inc. Class A Common Stock
$28.80BUSDP/E 11.4
UTHR
United Therapeutics Corporation - Common Stock
$23.23BUSDP/E 19.4
VTRS
Viatris Inc. - Common Stock
$20.22BUSD
SOBI
Swedish Orphan Biovitrum AB
$14.24BUSDP/E 109.4
NBIX
Neurocrine Biosciences, Inc. - Common Stock
$14.55BUSDP/E 21.0
IPN
Ipsen S.A.
$12.60BUSDP/E 22.8
ELAN
Elanco Animal Health Incorporated Common Stock
$11.06BUSD
RDY
Dr. Reddy's Laboratories Ltd Common Stock
$10.20BUSDP/E 29.2
KRK
Krka, d. d.
$8.50BUSDP/E 18.4
AMRX
Amneal Pharmaceuticals, Inc. - Class A Common Stock
$7.07BUSDP/E 42.3
ALKS
Alkermes plc - Ordinary Shares
$7.00BUSDP/E 109.9
HIMS
Hims & Hers Health, Inc. Class A Common Stock
$6.77BUSD
LNTH
Lantheus Holdings, Inc. - Common Stock
$6.53BUSDP/E 23.9
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
$5.83BUSDP/E 76.6
INDV
Indivior Pharmaceuticals, Inc. - Common Stock
$4.21BUSDP/E 12.8

Key Statistics

Company
Market Cap932.50M USD
Enterprise Value685.74M USD
Revenue (TTM)573.20M USD
Gross Profit426.98M USD
Net Income (TTM)62.35M USD
Revenue/Share45.71 EUR
Last Price73.80 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2.5K
CountryFR
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINFR0004186856
Valuation
P/E (Trailing)13.57
P/E (Forward)12.95
PEG3.80
EV/EBITDA5.88
EV/Revenue1.20
P/S1.62
P/B1.40
EPS (TTM)5.44
EPS (Forward)5.68
52W Range
65.7031% of range91.50
52W High91.50 EUR
52W Low65.70 EUR
Profitability
Gross Margin74.73%
Oper. Margin15.11%
EBITDA Margin20.34%
Profit Margin10.91%
ROE9.70%
ROA7.51%
Growth
Revenue Growth0.60%
Earnings Growth23.50%
Cash Flow & Leverage
Operating CF78.34M USD
CapEx (TTM)22.53M USD
FCF Margin13.81%
FCF Yield8.49%
Net Debt-242.23M USD
Net Debt/EBITDA-2.08
Balance Sheet
Debt/Equity0.03
Current Ratio3.35
Quick Ratio2.36
Book Value/Sh52.48 EUR
Cash/Share20.28 EUR
Dividends
Fwd Div Rate0.93 EUR
Trail. Div Rate0.93 EUR
Div. Yield1.26%
5Y Avg Yield0.80%
Payout Ratio17.10%
Ex-Div DateJun 3, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)91.50 EUR
Upside (mean)+24.0%
Target Range80.00 EUR – 110.00 EUR
80.00+24.0% to mean110.00
# Analysts4
Ownership
Shares Out.11.62M
Float3.65M
Insiders67.01%
Institutions13.07%
Technical
SMA 5072.23 (+2.2%)
SMA 20076.70 (-3.8%)
Beta0.87
S&P 52W Chg14.58%
Avg Vol (30d)9.50K
Avg Vol (10d)6.78K
Technical Indicators
RSI (14)50.1
MACD0.8882
MACD Signal1.0625
MACD Hist.-0.1743
BB Upper81.29 EUR
BB Middle73.78 EUR
BB Lower66.27 EUR
BB Width20.36%
ATR (14)1.945 EUR
Vol Ratio (20d)0.51x